Cargando…
Polygenic risk scores to stratify cancer screening should predict mortality not incidence
Population-based cancer screening programs such as mammography or colonscopy generally directed at all healthy individuals in a given age stratum. It has recently been proposed that cancer screening could be restricted to a high-risk subgroup based on polygenic risk scores (PRSs) using panels of sin...
Autores principales: | Vickers, Andrew J., Sud, Amit, Bernstein, Jonine, Houlston, Richard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9151796/ https://www.ncbi.nlm.nih.gov/pubmed/35637246 http://dx.doi.org/10.1038/s41698-022-00280-w |
Ejemplares similares
-
Will polygenic risk scores for cancer ever be clinically useful?
por: Sud, Amit, et al.
Publicado: (2021) -
The clinical utility of polygenic risk scores for chronic lymphocytic leukemia
por: Sud, Amit, et al.
Publicado: (2021) -
Realistic expectations are key to realising the benefits of polygenic scores
por: Sud, Amit, et al.
Publicado: (2023) -
Polygenic scores: prediction versus explanation
por: Plomin, Robert, et al.
Publicado: (2021) -
Post‐GWAS Polygenic Risk Score: Utility and Challenges
por: Nguyen, Tuan V, et al.
Publicado: (2020)